A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more ...

Scientists led by Northwestern University and Soochow University in China have built the first perovskite-based detector that ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...

A lead halide material can detect and image single gamma-ray photons with both high-spatial and high-energy resolution ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

A new study warns that GLP-1 weight-loss drugs like Ozempic and Wegovy may cause false cancer signals on PET-CT scans, ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Technological Advancements Drive Innovation in Medical Radiation Shielding SolutionsThe Global Medical Radiation Shielding ...

The rise of GLP-1s prescribed for weight loss and type 2 diabetes is leading to potentially misleading patterns in cancer scans.

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...